Treatments

There are many treatment options, both old and new, for cutaneous lymphomas. We offer an overview of available treatment choices that you can discuss with your healthcare provider. Together you can decide which treatment options may suit you best.

FUTURE DIRECTIONS IN T-CELL CUTANEOUS LYMPHOMA

Advances are being made in improving diagnostic tools. Dr. Christiane Quelfeld presents what has become available and what the future holds.

THERAPY SIDE EFFECTS

Cutaneous lymphoma experts provide answers to the question: "What are the common side effects for the therapies?"

DO I NEED TO SEE A SPECIALIST?

If a treatment center that has cutaneous lymphoma specialists isn't located nearby, what are your options? How important is it to see a specialist? Cutaneous lymphoma experts provide answers to the question: "Should I visit a specialty center and what if there isn't a specialty center close to me?"

Why do treatments take such a long time?

Starting a treatment plan is a very hopeful time. However your response may not be immediate. Why? Cutaneous lymphoma experts provide answers to the question: "Why do treatments take such a long time? If I choose an aggressive treatment would I get better quicker?"

Skin-Directed Therapies

Individuals with disease limited to the skin (stages I and II) can often achieve a good response with one of the readily available skin-directed therapies. Learn more about skin-directed therapies.
FROM GUIDE CONTRIBUTORS

Systemic Therapies

Individuals who have only partial or short responses to skin-directed therapies, or more advanced stages of disease, may benefit from systemic therapy. Learn more about available systemic therapies.

Cutaneous T-cell Lymphoma

CTCL stands for cutaneous T-cell lymphoma, a rare cancer of T-lymphocytes (a type of white blood cells) that involves the skin. There are several types of CTCL, but mycosis fungoides and Sézary syndrome are the most common. We've provided an overview of the disease, treatment and prognosis.
Physician & Patient

Clinical Trials: A Pathway to Treatment

Clinical trials are research studies that investigate new or experimental treatments in patients living with a specific disease. Clinical trials empower patients to play an active role in their own care and open them up to access new treatments before they are widely available.

SÉZARY SYNDROME

The two most common types of cutaneous T-cell lymphomas are mycosis fungoides and Sézary syndrome. Learn how Sézary syndrome is diagnosed, its treatments and prognosis.

A PRIMER ON EXTRA CORPOREAL PHOTOPHERESIS

Extracorporeal photopheresis (ECP) was the first therapy approved by the Food and Drug Administration (FDA) specifically for the treatment of cutaneous T-cell lymphoma. ECP may be an effective treatment for CTCL that has not responded to other types of therapy.

FUTURE DIRECTIONS IN T-CELL CUTANEOUS LYMPHOMA

Advances are being made in improving diagnostic tools. Dr. Christiane Quelfeld presents what has become available and what the future holds.

PHOTOTHERAPY IN A NUTSHELL

Phototherapy is the use of ultraviolet light to decrease inflammation in the skin. While phototherapy can be used in the treatment of many inflammatory skin conditions such as psoriasis and eczema, it has also been proven as an effective treatment for cutaneous T-cell lymphoma (CTCL).

What and when are combination therapies used?

Occasionally skin-directed therapies may be used in combination or with a systemic therapy when one therapy alone isn't fully effective.

GETTING A SECOND OPINION

When is getting a second opinion a good decision? Our panel of experts offer their recommendations on when you should seek out another professional opinion.